PT - JOURNAL ARTICLE AU - Kamo, Masashi AU - Murakami, Michio AU - Naito, Wataru AU - Takeshita, Jun-ichi AU - Yasutaka, Tetsuo AU - Imoto, Seiya TI - COVID-19 testing systems and their effectiveness in small, semi-isolated groups for sports events AID - 10.1101/2021.11.18.21266507 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.18.21266507 4099 - http://medrxiv.org/content/early/2021/11/21/2021.11.18.21266507.short 4100 - http://medrxiv.org/content/early/2021/11/21/2021.11.18.21266507.full AB - In this study, we quantitatively assessed the effectiveness of systems for COVID-19 testing in small groups of sport teams that are semi-isolated from the general population by countermeasures against infection. Two types of group were assumed, and the dynamics of infection within each group was modeled by using a compartment model of infectious disease. One group (Group A) comprised domestic professional sports teams that play many games over a season while remaining within a relatively small region. Polymerase chain reaction (PCR) tests were routinely conducted once every 2 weeks, and the number of infected individuals that could not be removed after identification by testing or checking for symptoms was defined as the risk. The other group (Group B) comprised teams that travel across borders for mass-gathering events like the Olympic and Paralympic Games. The teams were isolated for 2 weeks at their destination; frequent testing and checking for symptoms was conducted, and any infected individuals were removed. The number of infected individuals participating in games after the isolation period was defined as the risk. In Group A, the number of infected individuals detected by routinely conducted PCR testing was lower than the number of infected individuals detected by checking for symptoms, indicating that routine testing every 2 weeks was not very effective. In Group B, daily PCR testing was the most effective, followed by daily antigen testing. Dual testing, in which individuals with a positive antigen test were given an additional PCR test, was the least effective with an effect equal to PCR testing every other day. These results indicate that repeated testing does not necessarily increase the detection of infected individuals.Competing Interest StatementThis research project includes other members from two private companies, Kao Corporation and NVIDIA Corporation, Japan. W.N. received financial support from the Kao Corporation until March 2020 in a context outside the submitted work. T.Y. and W.N. have received financial support from the Kao Corporation for a collaborative research project in the context of measures at mass-gathering events. T.Y. and W.N. have received financial support from the Yomiuri Giants, the Japan Professional Football League, and the Japan Professional Basketball League. M.K., M.M., T.Y. W.N, and S.I. have attended the New Coronavirus Countermeasures Liaison Council jointly established by the Nippon Professional Baseball Organization and the Japan Professional Football League as experts without any reward. T.Y. and W.N. are advisors to the Japan National Stadium. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of any institution.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors